Top 10 Major Companies in the Taiwan Pleurisy Market | Insights & Key Players 2026

Top 10 Major Companies in the Taiwan Pleurisy Market

The Taiwan Pleurisy Market is influenced by a combination of local pharmaceutical companies and multinational subsidiaries, each making a considerable impact on the growth of the market through their robust R&D, manufacturing strengths, and focus on affordable generics. Major players in the market include Synmosa Biopharma, TTY Biopharm, and Standard Chem & Pharm.

Taiwan Pleurisy Market Overview

According to 6Wresearch, the market for Pleurisy in Taiwan is expected to grow, driven by an increase in the occurrence of respiratory infections, pneumonia, and tuberculosis, along with a rise in the awareness of the benefits of early intervention as a treatment. Pleurisy is known as an inflammation of the pleura, which is the membranes surrounding the lungs.

The market is driven by the growing ageing population, upgraded accessibility of healthcare, and the rising awareness of chronic diseases, which include respiratory ailments. Furthermore, the increase in healthcare expenditure, as well as the government’s support for the drug industry through the National Health Insurance administration, is expected to be beneficial for the market’s growth.

Competitive Landscape

The competitive landscape of the Taiwan Pleurisy industry is dominated by drug manufacturers with a longstanding market presence, as well as domestic companies that offer cost-effective products. The market players have managed to establish themselves in the market with the help of quality products, and R&D for new forms of anti-inflammatory and antibiotic treatments.

Below is a list of leading players operating in the Taiwan Pleurisy Market:

1. Synmosa Biopharma Corporation

Synmosa is a leader in the Taiwanese respiratory market, specializing in inhalers and anti-inflammatory treatments essential for managing pleural conditions.

2. TTY Biopharm Company Limited

TTY Biopharm produces advanced anti-infectives and specialized injectable drugs used in clinical settings for severe respiratory complications.

3. Standard Chem & Pharm Co., Ltd.

A prominent manufacturer of a wide range of generic medicines, including analgesics and anti-inflammatory agents used to alleviate pleuritic pain.

4. Yung Shin Pharmaceutical Ind. Co., Ltd.

One of Taiwan’s largest pharmaceutical firms, offering a diverse portfolio of antibiotics and respiratory medications to combat the underlying causes of pleurisy.

5. Lotus Pharmaceutical Co., Ltd.

A leading specialty generic company focusing on high-value products, including systemic treatments for inflammatory and respiratory conditions.

6. Sinphar Pharmaceutical Co., Ltd.

Sinphar provides various therapeutic solutions including anti-infective and respiratory health products designed for local and international markets.

7. Orient EuroPharma Co., Ltd. (OEP)

OEP is a vertically integrated player that distributes and manufactures high-quality pulmonary and anti-inflammatory medications.

8. AstraZeneca Taiwan

A global giant with a massive presence in Taiwan, providing innovative therapies for respiratory health and severe pulmonary inflammation.

9. GlaxoSmithKline (GSK) Taiwan

GSK is an industry leader in the respiratory field, supplying advanced inhalers and vaccines that prevent infections leading to pleurisy.

10. Sanofi Taiwan

Sanofi offers specialized treatments for respiratory diseases and a robust portfolio of anti-inflammatory medications relevant to pleural care.

Top 10 Major Companies in the Taiwan Pleurisy Market: FAQs